Outlookindia

Alembic Pharma Gets USFDA Approval For Ticagrelor Tablets, 60 mg

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.
Pharmabiz

Alembic Pharmaceuticals receives US FDA final approval for ticagrelor tablets, 60 mg

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ticagrelor tablets, 60 mg. The approved ANDA is ...
Business Standard

Alembic Pharma gets USFDA nod for Ticagrelor 60 mg tablets

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ticagrelor Tablets, 60 mg. The ...
cnbctv18

Alembic Pharma receives USFDA nod for drug for patients with acute coronary syndrome

Alembic Pharmaceuticals Ltd. on Wednesday, October 29, said it has received the US Food and Drug Administration's (USFDA) final approval for its abbreviated new drug application (ANDA) for the ...
businessupturn

Alembic Pharmaceuticals gets USFDA final approval for Ticagrelor Tablets 60 mg; targets $236 million market

Corporates RSWM signs investment agreements with Adani subsidiaries to secure 60 MW renewable power Oct 31, 2025 - 8:58 PM IST Corporates NTPC Green Energy signs MoU with CtrlS Datacenter to develop 2 ...